Symkevi Європейський Союз - латвійська - EMA (European Medicines Agency)

symkevi

vertex pharmaceuticals (ireland) limited - tezacaftor, ivacaftor - cistiskā fibroze - other respiratory system products - symkevi is indicated in a combination regimen with ivacaftor tablets for the treatment of patients with cystic fibrosis (cf) aged 6 years and older who are homozygous for the f508del mutation or who are heterozygous for the f508del mutation and have one of the following mutations in the cystic fibrosis transmembrane conductance regulator (cftr) gene: p67l, r117c, l206w, r352q, a455e, d579g, 711+3a→g, s945l, s977f, r1070w, d1152h, 2789+5g→a, 3272 26a→g, and 3849+10kbc→t.

Voriconazole Sciecure 200 mg pulveris infūziju šķīduma pagatavošanai Латвія - латвійська - Zāļu valsts aģentūra

voriconazole sciecure 200 mg pulveris infūziju šķīduma pagatavošanai

sciecure pharma ltd, united kingdom - vorikonazols - pulveris infūziju šķīduma pagatavošanai - 200 mg

Kaftrio Європейський Союз - латвійська - EMA (European Medicines Agency)

kaftrio

vertex pharmaceuticals (ireland) limited - ivacaftor, tezacaftor, elexacaftor - cistiskā fibroze - other respiratory system products - kaftrio is indicated in a combination regimen with ivacaftor for the treatment of cystic fibrosis (cf) in patients aged 6 years and older who have at least one f508del mutation in the cystic fibrosis transmembrane conductance regulator (cftr) gene.

Jimandin 100 mg apvalkotās tabletes Латвія - латвійська - Zāļu valsts aģentūra

jimandin 100 mg apvalkotās tabletes

medochemie ltd., cyprus - sitagliptīns - apvalkotā tablete - 100 mg